SCHEMBL1336749

SCHEMBL1336749

CCCCCCCCCCCCc1c[c]ccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ESR1 P03372 2/20 0.46
ADRA2A P08913 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
TACR2 P21452 2/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A3 Q01959 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
SHBG P04278 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
HSPD1 P10809 1/20 0.46
ADRB3 P13945 1/20 0.46
HTR2C P28335 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5210233 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL5209751 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL5207581 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL4865067 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL533252 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL828059 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL10602889 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL263493 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL20774553 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A
SCHEMBL4208084 1.00 KCNH2 (0.46) KCNH2TDP1L3MBTL1ESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217913-A2 PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND HUA MEDICINE (SHANGHAI) LTD. (CN) 2024-07-04 US claimed
US-20230312455-A1 PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND HUA MEDICINE (SHANGHAI) LTD. (CN) 2023-10-05 US claimed
CN-114085146-B Preparation of substituted acrylate compounds 华领医药技术(上海)有限公司 2023-09-01 CN claimed
EP-4206175-A1 PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND Hua Medicine (Shanghai) Ltd. (CN) 2023-07-05 EP claimed
CN-114085146-A Preparation of substituted acrylate compounds 华领医药技术(上海)有限公司 2022-02-25 CN claimed
US-7429548-B2 Soluble late transition metal catalysts for olefin oligomerizations III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2008-09-30 US claimed
EP-1620447-B1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEM PATENTS INC (US) 2007-08-08 EP claimed
US-7161018-B2 Soluble late transition metal catalysts for olefin oligomerizations II EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-01-09 US claimed
EP-1513854-B1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS EXXONMOBIL CHEM PATENTS INC (US) 2006-11-29 EP claimed
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US claimed
US-20240217913-A2 PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND HUA MEDICINE (SHANGHAI) LTD. (CN) 2024-07-04 US disclosed
CN-118244579-A Colored curable composition, color filter and display device 住友化学株式会社 2024-06-25 CN disclosed
CN-118244578-A Colored curable composition, color filter and display device 住友化学株式会社 2024-06-25 CN disclosed
CN-117916327-A Colored curable composition 住友化学株式会社 2024-04-19 CN disclosed
CN-117916326-A Colored curable composition 住友化学株式会社 2024-04-19 CN disclosed
US-5446180-A Compounds containing 1-aza-3-oxa-4-silacyclohex-1-enyl groups, and tautomers of said compounds DOW CORNING ASIA LTD. (JP) 1995-08-29 US disclosed
EP-0661290-A1 Compounds containing 1-aza-3-oxa-4-silacyclohex-1-enyl groups, and tautomers of said compounds DOW CORNING ASIA, Ltd. (JP) 1995-07-05 EP disclosed
EP-0451948-B1 Heterocyclicacetonitriles and their fungicidal use ROHM & HAAS (US) 1994-12-28 EP disclosed
US-5001091-A Readily moldable or castable ceramic powders NORTON COMPANY (US) 1991-03-19 US disclosed
US-4221918-A CATALYTIC HYDROGENATION OF CARBOXYLIC ANHYDRIDES CHEVRON RESEARCH COMPANY (US) 1980-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR KCNH2 2822/4885TDP1 3174/4885L3MBTL1 1451/4885
US-20230312455-A1 PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND ACR, ADCYAP1R1, GNPAT KCNH2 1859/4885TDP1 2871/4885L3MBTL1 4773/4885
US-20240217913-A2 PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND ACR, ADCYAP1R1, GNPAT KCNH2 1859/4885TDP1 2871/4885L3MBTL1 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.